1. Resuming oral anticoagulant (OAC) therapy after an OAC-related bleed was associated with higher rates of subsequent bleeding, but lower ...
Rates of rebleeding, thrombosis and mortality associated with resumption of anticoagulant therapy after anticoagulant-related bleeding 1. Resuming oral anticoagulant (OAC) ...
1. The incidence of having reduced antiplatelet activity to aspirin (ALR) increased after vascular procedures. Evidence Rating Level: 1 (Excellent) ...
Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas 1. Carboplatin, given through intracerebral, ...
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation dysfunction: ...
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation ...
1. The Perioperative Anticoagulation Use for Surgery Evaluation (PAUSE) cohort study evaluated the safety of standardized perioperative interruption of direct ...
1. Device thrombosis occurred at a higher rate in patients undergoing percutaneous coronary intervention (PCI) utilizing a bioabsorbable scaffold compared ...
1. In this unmatched case-control study, risk of cerebral venous thrombosis (CVT) amongst women on oral contraceptives increased in a ...
June 1 – June 9, 2013 In this section, we will highlight the some of the high-impact studies, updates, and ...
